Search

Your search keyword '"Sachith Abhayaratna"' showing total 2 results
Start Over Author "Sachith Abhayaratna" Publisher sri lanka college of endocrinologists
2 results on '"Sachith Abhayaratna"'

1. Diabetes Mellitus: Glucose Control

Author

Noel P Somasundaram, Chandrika N Wijeyaratne, Shamya De Silva, Sisira Siribaddana, Upali Illangasekera, Henry Rajaratnam, Prasad Katulanda, Uditha Bulugahapitiya, Sajith Siyambalapitiya, Charles Antonypillai, Manilka Sumanatilleke, Gaya Katulanda, Priyankara Jayawardena, N. Sudheera Kalupahana, Renuka Jayatissa, Chaminda Garusinghe, Dimuthu Muthukuda, Niranjala Meegoda Widanege, Muditha Weerakkody, Sivatharshya Pathmanathan, Sachith Abhayaratna, Shyaminda Kahandawa, Kavinga Gunawardane, Nayananjani Karunasena, M Aravindhan, WST Swarnasri, and Navoda Atapattu

Subjects
diabetes mellitus, glucose control, Diseases of the endocrine glands. Clinical endocrinology, RC648-665
Abstract

DOI: http://dx.doi.org/10.4038/sjdem.v3i1.5505 Sri Lanka Journal of Diabetes, Endocrinology and Metabolism 2013; 3: 45-37

Published
2013
Full Text
View/download PDF

2. The role of long term use of antithyroid drugs in Graves’ disease

Author

Noel Somasundaram and Sachith Abhayaratna

Subjects
Autoimmune disease, medicine.medical_specialty, Pediatrics, endocrine system diseases, Antithyroid drugs, business.industry, Graves' disease, radioactive iodine, Autoantibody, Disease, medicine.disease, RC648-665, graves’ disease, long term antithyroid drugs, Diseases of the endocrine glands. Clinical endocrinology, law.invention, Endocrinology, Randomized controlled trial, law, Internal medicine, Diabetes mellitus, medicine, Radioactive iodine, business
Abstract

Graves' disease is an autoimmune disease characterized by hyperthyroidism due to circulating autoantibodies. Radioactive iodine (RAI) and antithyroid drugs (ATD) are the preferred initial treatment options in Graves' disease in many parts of the world. Long term treatment with methimazole in Grave's disease patients beyond the recommended period is shown to be safe and effective and emerging evidence suggests that continuous methimazole therapy may even be superior to RAI therapy in some aspects. Recent randomized trials comparing long-term methimazole to RAI in patients who relapse, have confirmed these findings Sri Lanka Journal of Diabetes, Endocrinology and Metabolism 2013; 3: 41-44 DOI: http://dx.doi.org/10.4038/sjdem.v3i1.5503

Published
2013

Catalog

Books, media, physical & digital resources
See catalog results